Metformin produces modest but real weight loss in women with PCOS. Across randomized controlled trials, it reduces body weight by an average of about 3 kg (roughly 6.5 pounds) and lowers BMI by about 0.8 points. That’s meaningful, but it’s not dramatic, and it works best when paired with diet and exercise changes rather than used on its own.
How Metformin Works in PCOS
PCOS and insulin resistance are closely linked. When your cells don’t respond well to insulin, your body pumps out more of it to compensate. High insulin levels then trigger the ovaries to produce excess androgens (male hormones), which drive many PCOS symptoms: irregular periods, acne, hair growth, and stubborn weight gain, especially around the midsection.
Metformin targets this cycle at its root. It reduces the amount of glucose your liver releases into the bloodstream and makes your cells more responsive to insulin, so your body needs less of it. Lower circulating insulin means less signal for androgen production. It also activates a cellular energy sensor called AMPK, which shifts your metabolism toward burning stored fat and helps reduce triglyceride levels. The net effect is improved insulin sensitivity, less fat storage, and a body that’s more willing to let go of weight.
How Much Weight You Can Expect to Lose
A meta-analysis pooling data from randomized controlled trials found that metformin reduces body weight by an average of 3.13 kg (about 7 pounds) regardless of dose or treatment duration. BMI drops by roughly 0.82 points on average. One well-designed trial combining metformin with lifestyle changes saw a 3.4 kg drop at six months, with about 2 inches lost from the waist.
For comparison, lifestyle changes alone (structured diet and exercise programs) have produced weight losses of 8 to 10 kg in some PCOS studies over similar timeframes. And in the Diabetes Prevention Program, a large trial that included people with insulin resistance, metformin alone led to about 2 kg of weight loss at six months. So metformin helps, but it’s not a substitute for changing how you eat and move. It’s more like a metabolic nudge that makes those changes more effective.
When Results Typically Appear
Most clinical trials measure outcomes at three to six months, and that’s roughly the timeline you should expect. Some research shows measurable weight loss beginning around four weeks, with the most noticeable changes happening between weeks 8 and 12. If you’ve been taking metformin for six months and haven’t seen any shift in weight or waist measurement, it may not be the right tool for you, and that’s worth discussing with your provider.
Does It Work Differently for Lean vs. Obese PCOS
Not everyone with PCOS carries excess weight. About 20 to 30 percent of women with the condition have a normal BMI, sometimes called “lean PCOS.” Research suggests metformin actually improves hormonal and metabolic markers more effectively in lean women: one study found significant drops in testosterone, fasting glucose, and insulin resistance in lean participants but not in those with obesity. However, lean women didn’t lose weight or waist circumference on metformin either, because they didn’t have much to lose.
For women with obesity and PCOS, metformin produces more visible weight loss but may be less effective at correcting the underlying hormonal imbalances on its own. This is one reason treatment plans vary so much between patients.
How Metformin Compares to GLP-1 Medications
Newer injectable medications originally developed for type 2 diabetes, like liraglutide and semaglutide, have gained attention for PCOS-related weight loss. A systematic review comparing GLP-1 receptor agonists to metformin found that the newer drugs were significantly more effective at reducing BMI and waist circumference while also improving insulin sensitivity. One trial found that combining a GLP-1 medication with metformin produced about 6 kg of weight loss in 24 weeks, compared to 1.6 kg with metformin alone.
The trade-off is more side effects, particularly nausea and headaches. GLP-1 medications are also considerably more expensive and not always covered by insurance for PCOS specifically. Current international guidelines still position metformin as a first-line option for metabolic features of PCOS, noting that it has similar efficacy to active lifestyle intervention for cycle regulation and metabolic improvement.
Starting Metformin and Managing Side Effects
The most common barrier to sticking with metformin is gastrointestinal discomfort: nausea, bloating, diarrhea, and stomach cramps. These side effects are especially common in the first few weeks. The standard approach is to start low and go slow. Most providers begin with 500 mg taken with the largest meal of the day, then gradually increase to 500 mg with each meal over several weeks. The typical therapeutic range for PCOS is 1,500 to 2,550 mg per day.
Taking metformin with food makes a real difference. An extended-release formulation is also available and tends to cause fewer gut issues than the immediate-release version. If side effects are still intolerable after a gradual ramp-up, that’s useful information. Not everyone tolerates the drug well, and pushing through severe GI symptoms for months isn’t necessary when alternatives exist.
Long-Term Considerations
Metformin is generally well tolerated over years of use, which matters because PCOS is a chronic condition. The one thing to watch for is vitamin B12 deficiency. Studies of long-term metformin users report B12 deficiency in anywhere from 6 to 50 percent of patients, depending on how it’s measured and how long they’ve been on the medication. Low B12 can cause fatigue, numbness or tingling in the hands and feet, and difficulty concentrating. The American Diabetes Association recommends periodic B12 level checks for anyone on long-term metformin, and that applies to PCOS patients too. A simple blood test and, if needed, a B12 supplement can prevent problems.
Metformin also has benefits beyond the scale. It can help restore regular menstrual cycles, improve ovulation rates, lower androgen levels, and reduce markers of cardiovascular risk. For many women with PCOS, the weight loss is a welcome bonus on top of those hormonal and metabolic improvements, even if the number on the scale doesn’t drop as dramatically as they hoped.